about
Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityPreconditioning strategies for kidney ischemia reperfusion injury: implications of the "time-window" in remote ischemic preconditioningSerum neutrophil gelatinase-associated lipocalin and proinflammatory cytokines in pigs with septic versus non-septic acute kidney injury.Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity.Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer.Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice.Neutrophil gelatinase-associated lipocalin in blood in children with inflammatory bowel disease.
P2860
Q28728578-A316179A-9E9B-4D23-9654-6A7FC67028D4Q35448156-8584E223-DCD2-4806-858C-1FC6F098E848Q41649732-5317D89D-C659-4C2A-AA8F-FFB7091B6FB4Q42253266-D7539F7C-E37B-48A2-B915-608105949B97Q45005941-58403DB9-FEB1-454E-9DDA-66E9BCE507D1Q47690527-A21BC220-F0D3-4ADC-BC2A-4CA8C0840984Q53859552-375834A3-E13A-498A-BA0D-C1CC97F310CE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NGAL is a precocious marker of therapeutic response.
@en
NGAL is a precocious marker of therapeutic response.
@nl
type
label
NGAL is a precocious marker of therapeutic response.
@en
NGAL is a precocious marker of therapeutic response.
@nl
prefLabel
NGAL is a precocious marker of therapeutic response.
@en
NGAL is a precocious marker of therapeutic response.
@nl
P2093
P50
P1476
NGAL is a precocious marker of therapeutic response.
@en
P2093
Antoine Buemi
Eleonora Crascì
Michele Buemi
Silvia Lucisano
Valentina Donato
P304
P356
10.2174/138161211795428939
P577
2011-01-01T00:00:00Z